Tilson Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$391K Buy
6,450
+101
+2% +$5.89K 0.12% 62
2025
Q4
$342K Sell
6,349
-96
-1% -$4.62K 0.11% 66
2025
Q3
$291K Buy
6,445
+259
+4% +$12.1K 0.1% 67
2025
Q2
$286K Buy
6,186
+62
+1% +$3.04K 0.11% 61
2025
Q1
$374K Buy
6,124
+4
+0.1% +$233 0.15% 57
2024
Q4
$346K Buy
6,120
+40
+0.7% +$2.23K 0.14% 58
2024
Q3
$315K Buy
+6,080
New +$285K 0.14% 58
2024
Q2
Sell
-6,344
Closed -$344K 40
2024
Q1
$344K Buy
6,344
+86
+1% +$4.38K 0.18% 54
2023
Q4
$321K Buy
6,258
+221
+4% +$11.6K 0.21% 52
2023
Q3
$350K Buy
+6,037
New +$370K 0.28% 50

Other funds holding BMY

Tilson Financial Group's BMY Position: Q1 2026 in Review

Tilson Financial Group increased its Bristol-Myers Squibb (BMY) stake by 1.6% in Q1 2026, buying an estimated $5.89K and bringing the position to 6,450 shares worth $391K. The position accounts for 0.12% of the portfolio, ranked #62.

Tilson Financial Group first reported a position in BMY in Q3 2023 and has held it in 10 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Tilson Financial Group held 6,450 shares of Bristol-Myers Squibb worth $391K as of Q1 2026.
  • Tilson Financial Group bought 101 Bristol-Myers Squibb shares in Q1 2026, an estimated $5.89K.
  • Bristol-Myers Squibb made up 0.12% of Tilson Financial Group's portfolio in Q1 2026, its #62 holding.
  • Tilson Financial Group first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 10 quarters since.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Tilson Financial Group's 13F filing for Q1 2026, filed 29 Apr 2026.